Page 40 - Dr Stephanie Seneff - Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID - 19
P. 40
Steiner, J. A., Angot, E., and Brundin, P. (2011). A Deadly Spread: Cellular Mechanisms of α-Synuclein Transfer. Cell
Death and Differentiation 18: 1425-1433. https://www.doi.org/10.1038/cdd.2011.53.
Stokes, A., Pion, J., Binazon, O., Laffont, B., Bigras, M., Dubois, G. ... Rodriguez L.-A. (2020). Nonclinical Safety
Assessment of Repeated Administration and Biodistribution of a Novel Rabies Self-amplifying mRNA Vaccine in
Rats. Regulatory Toxicology and Pharmacology 113: 104648. https://doi.org/10.1016/j.yrtph.2020.104648.
Su, J. R., Moro, P. L., Ng, C. S., Lewis, P. W., Said, M. A., & Cano, M.V. (2019). Anaphylaxis after vaccination reported
to theVaccine Adverse Event Reporting System, 1990-2016.Journal of Allergy and Clinical Immunology 143(4):
1465-1473. https://doi.org/10.1016/j.jaci.2018.12.1003.
Sun, R.-J. & Shan, N.-N. (2019). Megakaryocytic Dysfunction in Immune Thrombocytopenia is Linked to Autophagy
Cancer Cell International 19: 59. https://doi.org/10.1186/s12935-019-0779-0.
Suzuki, Y. J. & Gychka, S. G. (2021). SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells:
Implications for Possible Consequences of COVID-19 Vaccines. Vaccines 9: 36.
https://doi.org/10.3390/vaccines9010036.
Suzuki, Y. J. (2020). The Viral Protein Fragment Theory of COVID-19 Pathogenesis. Medical Hypotheses 144: 110267.
https://doi.org/10.1016/j.mehy.2020.110267.
Suzuki, Y. J., Nikolaienko, S. I., Dibrova, V. A., Dibrova, Y. V., Vasylyk, V. M., Novikov, M. Y. ... Gychka, S. G. (2021).
SARS-CoV-2 Spike Protein-Mediated Cell Signaling in Lung Vascular Cells. Vascular Pharmacology 137: 106823.
https://doi.org/10.1016/j.vph.2020.106823.
Suzuki, Y.J., Nikolaienko, S.I., Dibrova, V.A., Dibrova, Y.V., Vasylyk, V.M., Novikov, M.Y. ... Gychka, S.G. (2020).
SARS-CoV-2 Spike Protein-Mediated Cell Signaling in Lung Vascular Cells. Vascular Pharmacology 137: 106823.
https://www.doi.org/10.1016/j.vph.2020.106823.
Takada, A., Feldmann, H., Ksiazek, T. G. & Kawaoka, Y. (2003). Antibody-Dependent Enhancement of Ebola Virus
Infection. Virology 77(13): 7539-7544. https://doi.org/10.1128/JVI.77.13.7539-7544.2003.
Temin, H. M. and Mizutani, S. (1970). RNA-dependent DNA polymerase in virions of Rous Sarcoma Virus. Nature 226:
1211–3. https://www.doi.org/10.1038/2261211a0.
Tetz, G. and Tetz, V. (2020). SARS-CoV-2 Prion-Like Domains in Spike Proteins Enable Higher Affinity to ACE2.
Preprints 2020030422. https://www.doi.org/10.20944/preprints202003.0422.v1.
Tetz, G. and Tetz,V (2018). Prion-like Domains in Eukaryotic Viruses. Scientific Reports 8: 8931.
https://doi.org/10.1038/s41598-018-27256-w.
U.S. Department of Health and Human Services, Food and Drug Administration. Center for Biologics Evaluation and
Research. (2020, June) Development and Licensure of Vaccines to Prevent COVID-19 Guidance for Industry.
Retrieved February 11, 2021 from https://www.fda.gov/regulatory-information/search-fda-guidance-
documents/development-and-licensure-vaccines-prevent-covid-19.
US Food and Drug Administration (2021). Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare
Providers Administering Vaccine (Vaccination Providers). https://www.fda.gov/media/144413
Verma, S., Saksena, S. & Sadri-Ardekani, H. (2020). ACE2 Receptor Expression in Testes: Implications in Coronavirus
Disease 2019 Pathogenesis. Biology of Reproduction 103(3): 449-451. https://doi.org/10.1093/biolre/ioaa080.
Vlachoyiannopoulos, P. G., Magira, E., Alexopoulos, H., Jahaj, E., Theophilopoulou, K., Kotanidou, A., & Tzioufas, A.
G. (2020). Autoantibodies Related to Systemic Autoimmune Rheumatic Diseases in Severely Ill Patients with
COVID-19. Annals of the Rheumatic Diseases 79(12): 1661-1663. http://dx.doi.org/10.1136/annrheumdis-2020-
218009.
Vaidya, M. and Sugaya, K (2020). DNA Associated with Circulating Exosomes as a Biomarker for Glioma. Genes 11:
1276. https://www.doi.org/10.3390/genes11111276.
Vojdani, A., & Kharrazian, D. (2020). Potential Antigenic Cross-Reactivity Between SARS-CoV-2 and Human Tissue
with a Possible Link to an Increase in Autoimmune Diseases. Clinical Immunology (Orlando, Fla.) 217: 108480.
https://doi.org/10.1016/j.clim.2020.108480.
Vojdani, A., Vojdani, E., & Kharrazian, D. (2021). Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins
International Journal of Vaccine Theory, Practice, and Research 2(1), May 10, 2021 Page | 428
